271 related articles for article (PubMed ID: 8176208)
1. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
Pinet V; Malnati MS; Long EO
J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
[TBL] [Abstract][Full Text] [Related]
2. Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC.
Malnati MS; Ceman S; Weston M; DeMars R; Long EO
J Immunol; 1993 Dec; 151(12):6751-6. PubMed ID: 8258689
[TBL] [Abstract][Full Text] [Related]
3. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.
Dodi AI; Brett S; Nordeng T; Sidhu S; Batchelor RJ; Lombardi G; Bakke O; Lechler RI
Eur J Immunol; 1994 Jul; 24(7):1632-9. PubMed ID: 8026524
[TBL] [Abstract][Full Text] [Related]
4. Class II MHC molecules can use the endogenous pathway of antigen presentation.
Nuchtern JG; Biddison WE; Klausner RD
Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
[TBL] [Abstract][Full Text] [Related]
5. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
Long EO; LaVaute T; Pinet V; Jaraquemada D
J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
[TBL] [Abstract][Full Text] [Related]
6. Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation.
Hackett CJ; Yewdell JW; Bennink JR; Wysocka M
J Immunol; 1991 May; 146(9):2944-51. PubMed ID: 1673146
[TBL] [Abstract][Full Text] [Related]
7. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells.
Malnati MS; Marti M; LaVaute T; Jaraquemada D; Biddison W; DeMars R; Long EO
Nature; 1992 Jun; 357(6380):702-4. PubMed ID: 1614517
[TBL] [Abstract][Full Text] [Related]
8. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
[TBL] [Abstract][Full Text] [Related]
9. Antigen presentation mediated by recycling of surface HLA-DR molecules.
Pinet V; Vergelli M; Martin R; Bakke O; Long EO
Nature; 1995 Jun; 375(6532):603-6. PubMed ID: 7540726
[TBL] [Abstract][Full Text] [Related]
10. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
12. Murine cell lines stably expressing the influenza virus hemagglutinin gene introduced by a recombinant retrovirus vector are constitutive targets for MHC class I- and class II-restricted T lymphocytes.
Eager KB; Hackett CJ; Gerhard WU; Bennink J; Eisenlohr LC; Yewdell J; Ricciardi RP
J Immunol; 1989 Oct; 143(7):2328-35. PubMed ID: 2789261
[TBL] [Abstract][Full Text] [Related]
13. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
[TBL] [Abstract][Full Text] [Related]
14. The role of the endoplasmic reticulum in antigen processing. N-glycosylation of influenza hemagglutinin abrogates CD4+ cytotoxic T cell recognition of endogenously processed antigen.
Thomas DB; Hodgson J; Riska PF; Graham CM
J Immunol; 1990 Apr; 144(7):2789-94. PubMed ID: 1690778
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
16. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
17. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
18. Viral peptide specific induction of MHC class II expression by murine T cell clones.
Thomas DB; Smith CA; Graham CM
J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
[TBL] [Abstract][Full Text] [Related]
19. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
20. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.
Roche PA; Cresswell P
Nature; 1990 Jun; 345(6276):615-8. PubMed ID: 2190094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]